LONDON, February 27, 2015 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Investor-Edge.com has issued free post-earnings review on The Dow Chemical Co. (NYSE: DOW). On January 29, 2015, the company reported its financial results for Q4 FY14 and full year FY14 (period ended December 31, 2014). Click on http://get.Investor-Edge.com/pdf/?c=Dow%20Chemical&d=27-Feb-2015&s=DOW to read our free earnings review on The Dow Chemical Company (Dow Chemical). For Q4 FY14 and full-year FY14, the company's adjusted earnings per share (EPS) grew 31% Y-o-Y and 25% Y-o-Y, respectively. President, Chairman, and CEO of Dow Chemical, Andrew N. Liveris, stated that the company achieved a record end to a strong year, with another quarter of Y-o-Y operating EPS, earnings before interest, income taxes, depreciation and amortization (EBITDA) and EBITDA margin growth. He also informed that it was nine quarters in a row of these metrics registering Y-O-Y growth. Our free coverage report can be accessed at:

http://get.Investor-Edge.com/pdf/?c=Dow%20Chemical&d=27-Feb-2015&s=DOW

Earnings Overview

During Q4 FY14, Dow Chemical's net sales came in at $14.38 billion, slightly lower as compared to $14.39 billion in Q4 FY13. The company's Q4 FY14 net sales missed Bloomberg analysts' expectations of $14.46 billion. Dow Chemical reported record adjusted EBITDA of $2.42 billion in Q4 FY14 compared to $2.10 billion in Q4 FY13, which was a 15% Y-o-Y increase. For Q4 FY14, Adjusted EBITDA was up in all operating segments led by growth of 40% Y-o-Y in Agricultural Sciences segment, 18% Y-o-Y in Performance Materials & Chemicals segment, and 6% Y-o-Y in Performance Plastic segment. Free research on DOW can be downloaded in PDF format at:

http://get.Investor-Edge.com/pdf/?c=Dow%20Chemical&d=27-Feb-2015&s=DOW

In Q4 FY14, net income available to Dow Chemical common stockholders was $734 million, or $0.63 per diluted share, compared to $963 million, or $0.79 per diluted share, in Q4 FY13. Bloomberg analysts' had expected Q4 FY14 net income available to common stockholders of $788 million, or $0.69 per diluted share. The company reported adjusted net income of $992 million, or $0.85 per diluted share, in Q4 FY14, compared to $793 million, or $0.65 per diluted share in Q4 FY13.

Dow Chemical' cash flow from operations increased by more than $500 million Y-o-Y to $2.8 billion in Q4 FY14. Furthermore, in Q4 FY14, the company returned $1.6 billion to shareholders through dividends and share repurchases. The company completed its $4.5 billion repurchase program in the reported quarter. During the quarter, the Company also announced a 14% dividend increase and expanded its share buyback program by an additional $5 billion. Sign up and read the free analyst's notes on DOW at:

http://get.Investor-Edge.com/pdf/?c=Dow%20Chemical&d=27-Feb-2015&s=DOW

During FY14, Dow Chemical's net sales improved to $58.17 billion from $57.08 billion in FY13. The company's FY14 net sales missed Bloomberg analysts' forecast of $58.28 billion. For FY14, net income available to Dow Chemical common stockholders came in at $3.43 billion, or $2.87 per diluted share, compared to $4.45 billion, or $3.68 per diluted share, in FY13. Analysts at Bloomberg had expected net income available to common stockholders of $3.50 billion, or $2.95 per diluted share.

Commenting on the company's outlook, Mr. Liveris declared that even against the backdrop of ongoing macroeconomic, currency and energy market uncertainty, the company continues to see positive underlying demand fundamentals. He asserted that Dow Chemical is well positioned to continue to optimize returns in this environment. The company's advantaged global cost positions are enabling Dow Chemical to increase asset utilization, while selling into higher value sectors. Tightening supply and demand is acting to offset some of the challenges that are a result of falling oil prices, he added. Visit Investor-Edge and access the latest research on DOW at:

http://get.Investor-Edge.com/pdf/?c=Dow%20Chemical&d=27-Feb-2015&s=DOW

Stock Performance

On the day of the earnings release, January 29, 2015, Dow Chemical's stock surged 4.60% finishing the session at $45.01. Since then, the stock has mostly witnessed a positive momentum. However, on the last close, Thursday, February 26, 2015, the company's shares finished 1.20% lower at $49.25. The company's shares vacillated between $49.04 and $49.85 during the session. A total of 7.22 million shares were traded which was below their three months average volume of 9.56 million shares. Over the last one month and past one year, Dow Chemical's shares have gained 10.53% and 2.97%, respectively. However, the stock has fallen by 4.85% over the previous three months. Shares in the company closed above their 50-day moving average of $45.96.

Sneak Peek to Corporate Insider Trading

In the last one month, there were 13 corporate insider transactions done by 13 individuals. Between February 06, 2015 and February 11, 2015, a total of 6,228 shares have been purchased at an average price of $48.20 per share and for a total value of $300,213. During the stated period, a total of 113,964 shares, worth $5.51 million, were sold at an average price of $48.38 per share. The following are few of the key transactions during the aforementioned period: on February 10, 2015, Andrew N. Liveris and Charles J. Kalil, General Counsel and Executive Vice President at Dow Chemical, disposed 38,401 and 8,794 shares, respectively, at an average price of $48.50 per share, while on the same day Arnold A. Allemang, Director at Dow Chemical, sold 37,800 shares at an average price of $48.15 per share. Complimentary in-depth research on DOW is available at:

http://get.Investor-Edge.com/pdf/?c=Dow%20Chemical&d=27-Feb-2015&s=DOW

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge